Comparison of information-dependent acquisition, SWATH, and MS(All) techniques in metabolite identification study employing ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry.

Sensitive and selective liquid chromatography-mass spectrometry (LC-MS) analysis is a powerful and essential tool for metabolite identification in drug discovery and development. An MS(2) (or tandem, MS/MS) mass spectrum is acquired from the fragmentation of a precursor ion by multiple methods including information-dependent acquisition (IDA), SWATH (sequential window acquisition of all theoretical fragment-ion spectra), and MS(All) (also called MS(E)) techniques. We compared these three techniques in their capabilities to produce comprehensive MS(2) data by assessing both metabolite MS(2) acquisition hit rate and the quality of MS(2) spectra. Rat liver microsomal incubations from eight test compounds were analyzed with four methods (IDA, MMDF (multiple mass defect filters)-IDA, SWATH, or MS(All)) using an ultrahigh-performance liquid chromatography-qudrupole time-of-flight mass spectrometry (UHPLC-Q-TOF MS) platform. A combined total of 227 drug-related materials (DRM) were detected from all eight test article incubations, and among those, 5% and 4% of DRM were not triggered for MS(2) acquisition with IDA and MMDF-IDA methods, respectively. When the same samples were spiked to an equal volume of blank rat urine (urine sample), the DRM without MS(2) acquisition increased to 29% and 18%, correspondingly. In contrast, 100% of DRM in both matrixes were subjected to MS(2) acquisition with either the SWATH or MS(All) method. However, the quality of the acquired MS(2) spectra decreased in the order of IDA, SWATH, and MS(All) methods. An average of 10, 9, and 6 out of 10 most abundant ions in MS(2) spectra were the real product ions of DRM detected in microsomal samples from IDA, SWATH, and MS(All) methods, respectively. The corresponding numbers declined to 9, 6, and 3 in the urine samples. Overall, IDA-based methods acquired qualitatively better MS(2) spectra but with a lower MS(2) acquisition hit rate than the other two methods. SWATH outperformed the MS(All) method given its better quality of MS(2) spectra with an identical MS(2) acquisition hit rate.

[1]  Jennifer H Granger,et al.  Increasing throughput and information content for in vitro drug metabolism experiments using ultra-performance liquid chromatography coupled to a quadrupole time-of-flight mass spectrometer. , 2005, Rapid communications in mass spectrometry : RCM.

[2]  Mingshe Zhu,et al.  Drug Metabolite Profiling and Identification by High-resolution Mass Spectrometry* , 2011, The Journal of Biological Chemistry.

[3]  Vladislav A Petyuk,et al.  Mass spectrometry for translational proteomics: progress and clinical implications , 2012, Genome Medicine.

[4]  Mark Wrona,et al.  MSE with mass defect filtering for in vitro and in vivo metabolite identification. , 2007, Rapid communications in mass spectrometry : RCM.

[5]  Ari Tolonen,et al.  Comparison of triple quadrupole, hybrid linear ion trap triple quadrupole, time-of-flight and LTQ-Orbitrap mass spectrometers in drug discovery phase metabolite screening and identification in vitro--amitriptyline and verapamil as model compounds. , 2010, Rapid communications in mass spectrometry : RCM.

[6]  B. Simons,et al.  Performance characteristics of a new hybrid quadrupole time-of-flight tandem mass spectrometer (TripleTOF 5600). , 2011, Analytical chemistry.

[7]  I. Chernushevich,et al.  An introduction to quadrupole-time-of-flight mass spectrometry. , 2001, Journal of mass spectrometry : JMS.

[8]  J. Langridge,et al.  A novel precursor ion discovery method on a hybrid quadrupole orthogonal acceleration time-of-flight (Q-TOF) mass spectrometer for studying protein phosphorylation , 2002, Journal of the American Society for Mass Spectrometry.

[9]  G. Bowers,et al.  Metabolite structure analysis by high-resolution MS: supporting drug-development studies. , 2013, Bioanalysis.

[10]  Patricia Wright,et al.  Metabolite identification by mass spectrometry: forty years of evolution , 2011, Xenobiotica; the fate of foreign compounds in biological systems.

[11]  A. Millar,et al.  Investigation of isomeric transformations of chlorogenic acid in buffers and biological matrixes by ultraperformance liquid chromatography coupled with hybrid quadrupole/ion mobility/orthogonal acceleration time-of-flight mass spectrometry. , 2011, Journal of agricultural and food chemistry.

[12]  M. Holčapek,et al.  Recent developments in liquid chromatography-mass spectrometry and related techniques. , 2012, Journal of chromatography. A.

[13]  Angus Nedderman,et al.  Analytical strategies for identifying drug metabolites. , 2007, Mass spectrometry reviews.

[14]  S. Chowdhury,et al.  Application of LC-high-resolution MS with 'intelligent' data mining tools for screening reactive drug metabolites. , 2012, Bioanalysis.

[15]  Xiaoyan Chen,et al.  Metabolism of Flumatinib, a Novel Antineoplastic Tyrosine Kinase Inhibitor, in Chronic Myelogenous Leukemia Patients , 2010, Drug Metabolism and Disposition.

[16]  R. Plumb,et al.  Investigating the human metabolism of acetaminophen using UPLC and exact mass oa-TOF MS. , 2005, Journal of pharmaceutical and biomedical analysis.

[17]  Xiaoyan Chen,et al.  Identification of Amiodarone Metabolites in Human Bile by Ultraperformance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry , 2011, Drug Metabolism and Disposition.

[18]  Sean Yu,et al.  High-throughput, accurate mass liquid chromatography/tandem mass spectrometry on a quadrupole time-of-flight system as a 'first-line' approach for metabolite identification studies. , 2008, Rapid communications in mass spectrometry : RCM.

[19]  Yan Liang,et al.  Recent development in liquid chromatography/mass spectrometry and emerging technologies for metabolite identification. , 2011, Current drug metabolism.

[20]  Ludovic C. Gillet,et al.  Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome Analysis* , 2012, Molecular & Cellular Proteomics.

[21]  Xiaoyan Chen,et al.  Identification of 20(S)-Protopanaxadiol Metabolites in Human Liver Microsomes and Human Hepatocytes , 2011, Drug Metabolism and Disposition.

[22]  Gérard Hopfgartner,et al.  High-resolution mass spectrometry for integrated qualitative and quantitative analysis of pharmaceuticals in biological matrices , 2012, Analytical and Bioanalytical Chemistry.

[23]  Eric Yang,et al.  A high-throughput liquid chromatography/tandem mass spectrometry method for screening glutathione conjugates using exact mass neutral loss acquisition. , 2005, Rapid communications in mass spectrometry : RCM.

[24]  Stefan Blech,et al.  Resolving the microcosmos of complex samples: UPLC/travelling wave ion mobility separation high resolution mass spectrometry for the analysis of in vivo drug metabolism studies , 2013, International Journal for Ion Mobility Spectrometry.

[25]  Mark Wrona,et al.  'All-in-one' analysis for metabolite identification using liquid chromatography/hybrid quadrupole time-of-flight mass spectrometry with collision energy switching. , 2005, Rapid communications in mass spectrometry : RCM.

[26]  K. Alton,et al.  Application of mass spectrometry for metabolite identification. , 2006, Current drug metabolism.

[27]  Shuguang Ma,et al.  Data acquisition and data mining techniques for metabolite identification using LC coupled to high-resolution MS. , 2013, Bioanalysis.

[28]  Iain Beattie,et al.  Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.

[29]  Dafang Zhong,et al.  Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS. , 2012, Bioanalysis.

[30]  C. V. Van Peteghem,et al.  Information-dependent acquisition-mediated LC-MS/MS screening procedure with semiquantitative potential. , 2004, Analytical chemistry.